A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota

Yu Yang,Yifan Chang,Yi Wu,Hairong Liu,Qishan Liu,Zuzhe Kang,Man Wu,Hong Yin,Jinyou Duan
DOI: https://doi.org/10.1016/j.ijbiomac.2021.05.209
IF: 8.2
2021-07-01
International Journal of Biological Macromolecules
Abstract:<p><em>Lycium barbarum</em> polysaccharides (LBPs) are known for their beneficial effects on diabetes, NAFLD and related chronic metabolic diseases induced by high-fat diet (HFD). However, the relevant researches are mainly about the whole crude polysaccharides, the specific active ingredient of LBPs and its bioactivity have been rarely explored. Herein, a homogeneous polysaccharide (LBP-W) was isolated and purified from crude LBPs. Structure characterizations indicated that LBP-W contained a main chain consisting of a repeated unit of →6)-β-Gal<em>p</em>(1 → residues with branches composed of α-Ara<em>f</em>, β-Gal<em>p</em> and α-Rha<em>p</em> residues at position C-3. The objective of this study was to evaluate the anti-obesogenic effect of LBP-W and figure out the underlying mechanisms. <em>In vivo</em> efficacy trial illustrated that LBP-W supplements can alleviate HFD-induced mice obesity significantly. Gut microbiota analysis showed that LBP-W not only improved community diversity of intestinal flora, but also regulated their specific genera. Moreover, LBP-W can increase the content of short-chain fatty acids (SCFAs), a metabolite of the intestinal flora. In summary, all these results demonstrated that the homogeneous polysaccharide purified from <em>L. barbarum</em> could be used as a prebiotic agent to improve obesity by modulating the composition of intestinal flora and the metabolism of SCFAs.</p>
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?